These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1832087)
1. Cytolytic activities of activated macrophages versus paraformaldehyde-fixed macrophages; soluble versus membrane-associated TNF. Fishman M Cell Immunol; 1991 Oct; 137(1):164-74. PubMed ID: 1832087 [TBL] [Abstract][Full Text] [Related]
2. TPA induction of EL4 resistance to macrophage-released TNF: role of ADP-ribosylation in tumoricidal activities of TNF and other factors. Fishman M; Essani N; Costlow M Cell Immunol; 1990 Apr; 127(1):78-91. PubMed ID: 2138520 [TBL] [Abstract][Full Text] [Related]
3. Differences in the tumor necrosis factor-alpha-mediated lysis by fixed natural cytotoxic cells and fixed cytotoxic macrophages. Vanderslice WE; Collins JL J Immunol; 1991 Jan; 146(1):156-61. PubMed ID: 1984442 [TBL] [Abstract][Full Text] [Related]
4. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells. Remels L; Fransen L; Huygen K; De Baetselier P J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350 [TBL] [Abstract][Full Text] [Related]
5. TNF induction of EL4 hyposensitivity to lysis by recombinant (soluble) and membrane-associated TNFs: TNF binding, internalization, and degradation. Fishman M; Costlow M Cell Immunol; 1994 Apr; 154(1):453-67. PubMed ID: 8131213 [TBL] [Abstract][Full Text] [Related]
6. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes. Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697 [TBL] [Abstract][Full Text] [Related]
7. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. Jiang H; Stewart CA; Fast DJ; Leu RW J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576 [TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both. Ichinose Y; Bakouche O; Tsao JY; Fidler IJ J Immunol; 1988 Jul; 141(2):512-8. PubMed ID: 3260254 [TBL] [Abstract][Full Text] [Related]
9. Leukemic cell lysis by activated human macrophages: significance of membrane-associated tumor necrosis factor. Nakabo Y; Harakawa N; Yamamoto K; Okuma M; Uno K; Sasada M Jpn J Cancer Res; 1993 Nov; 84(11):1174-80. PubMed ID: 8276722 [TBL] [Abstract][Full Text] [Related]
10. Cytolysis of adenovirus-infected murine fibroblasts by IFN-gamma-primed macrophages is TNF- and contact-dependent. Day DB; Zachariades NA; Gooding LR Cell Immunol; 1994 Aug; 157(1):223-38. PubMed ID: 8039246 [TBL] [Abstract][Full Text] [Related]
11. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma. Levesque MC; Haynes BF J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292 [TBL] [Abstract][Full Text] [Related]
12. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells. Nii A; Fidler IJ Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of leukemic cell lysis by activated human macrophages: leukemic cells can be lysed without direct contact. Nakabo Y; Harakawa N; Yamamoto K; Okuma M; Uno K; Sasada M Int J Hematol; 1994 Jul; 60(1):51-7. PubMed ID: 7919238 [TBL] [Abstract][Full Text] [Related]
14. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor. Howard AD; Erickson KL Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340 [TBL] [Abstract][Full Text] [Related]
15. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240 [TBL] [Abstract][Full Text] [Related]
16. Study of the dependence of human monocytes and macrophages antitumoral properties upon TNF-alpha expression or release. Dumont S; Mabondzo A; Hartmann D; Gilgenkrantz JL; Kessler R; Poindron P; Bartholeyns J Anticancer Res; 1990; 10(4):949-54. PubMed ID: 2116753 [TBL] [Abstract][Full Text] [Related]
17. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. Decker T; Lohmann-Matthes ML; Gifford GE J Immunol; 1987 Feb; 138(3):957-62. PubMed ID: 3492537 [TBL] [Abstract][Full Text] [Related]
18. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production. Leu RW; Leu NR; Shannon BJ; Fast DJ J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha. Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228 [TBL] [Abstract][Full Text] [Related]
20. IL-2. A cofactor for induction of activated macrophage resistance to infection. Belosevic M; Finbloom DS; Meltzer MS; Nacy CA J Immunol; 1990 Aug; 145(3):831-9. PubMed ID: 2115543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]